Mitochondriale neurogastrointestinale Enzephalomyopathie

Amiot A, Tchikviladze M, Joly F et al (2009) Frequency of mitochondrial defects in patients with chronic intestinal pseudo-obstruction. Gastroenterology 137:101–109

Ariaudo C, Daidola G, Ferrero B et al (2015) Mitochondrial neurogastrointestinal encephalomyopathy treated with peritoneal dialysis and bone marrow transplantation. J Nephrol 28:125–127

Bax BE, Bain MD, Scarpelli M et al (2013) Clinical and biochemical improvements in a patient with MNGIE following enzyme replacement. Neurology 81:1269–1271

Boschetti E, D’alessandro R, Bianco F et al (2014) Liver as a source for thymidine phosphorylase replacement in mitochondrial neurogastrointestinal encephalomyopathy. PLOS ONE 9:e96692

D’angelo R, Rinaldi R, Carelli V et al (2016) ITA-MNGIE: an Italian regional and national survey for mitochondrial neuro-gastro-intestinal encephalomyopathy. Neurol Sci 37:1149–1151

De Giorgio R, Pironi L, Rinaldi R et al (2016) Liver transplantation for mitochondrial neurogastrointestinal encephalomyopathy. Ann Neurol 80:448–455

De Vocht C, Ranquin A, Willaert R et al (2009) Assessment of stability, toxicity and immunogenicity of new polymeric nanoreactors for use in enzyme replacement therapy of MNGIE. J Control Release 137:246–254

Demaria F, De Crescenzo F, Caramadre AM et al (2016) Mitochondrial neurogastrointestinal encephalomyopathy presenting as anorexia nervosa. J Adolesc Health 59:729–731

Finsterer J, Shorny S, Capek J et al (1998) Lactate stress test in the diagnosis of mitochondrial myopathy. J Neurol Sci 159:176–180

Gamez J, Lara MC, Mearin F et al (2005) A novel thymidine phosphorylase mutation in a Spanish MNGIE patient. J Neurol Sci 228:35–39

Garone C, Tadesse S, Hirano M (2011) Clinical and genetic spectrum of mitochondrial neurogastrointestinal encephalomyopathy. Brain 134:3326–3332

Giordano C, Sebastiani M, De Giorgio R et al (2008) Gastrointestinal dysmotility in mitochondrial neurogastrointestinal encephalomyopathy is caused by mitochondrial DNA depletion. Am J Pathol 173:1120–1128

Giordano C, Sebastiani M, Plazzi G et al (2006) Mitochondrial neurogastrointestinal encephalomyopathy: evidence of mitochondrial DNA depletion in the small intestine. Gastroenterology 130:893–901

Halter J, Schupbach WM, Casali C et al (2011) Allogeneic hematopoietic SCT as treatment option for patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a consensus conference proposal for a standardized approach. Bone Marrow Transplant 46:330–337

Halter JP, Michael W, Schupbach M et al (2015) Allogeneic haematopoietic stem cell transplantation for mitochondrial neurogastrointestinal encephalomyopathy. Brain 138:2847–2858

Hirano M, Nishigaki Y, Marti R (2004) Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a disease of two genomes. Neurologist 10:8–17

Hirano M, Silvestri G, Blake DM et al (1994) Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder. Neurology 44:721–727

La Marca G, Malvagia S, Casetta B et al (2006) Pre- and post-dialysis quantitative dosage of thymidine in urine and plasma of a MNGIE patient by using HPLC-ESI-MS/MS. J Mass Spectrom 41:586–592

Lara MC, Weiss B, Illa I et al (2006) Infusion of platelets transiently reduces nucleoside overload in MNGIE. Neurology 67:1461–1463

Moran NF, Bain MD, Muqit MM et al (2008) Carrier erythrocyte entrapped thymidine phosphorylase therapy for MNGIE. Neurology 71:686–688

Nishino I, Spinazzola A, Hirano M (1999) Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science 283:689–692

Okamura K, Santa T, Nagae K et al (1976) Congenital oculoskeletal myopathy with abnormal muscle and liver mitochondria. J Neurol Sci 27:79–91

Scheffer RC, Smout AJ (2011) Tachyduodenia in mitochondrial neurogastrointestinal encephalomyopathy. Neurogastroenterol Motil 23:408–410

Spinazzola A, Marti R, Nishino I et al (2002) Altered thymidine metabolism due to defects of thymidine phosphorylase. J Biol Chem 277:4128–4133

Yadak R, Sillevis Smitt P, Van Gisbergen MW et al (2017) Mitochondrial neurogastrointestinal encephalomyopathy caused by thymidine phosphorylase enzyme deficiency: from pathogenesis to emerging therapeutic options. Front Cell Neurosci 11:31

Yavuz H, Ozel A, Christensen M et al (2007) Treatment of mitochondrial neurogastrointestinal encephalomyopathy with dialysis. Arch Neurol 64:435–438

Zimmer V, Feiden W, Becker G et al (2009) Absence of the interstitial cell of Cajal network in mitochondrial neurogastrointestinal encephalomyopathy. Neurogastroenterol Motil 21:627–631

Zimmer V, Hirano M, Zimmer A et al (2014) Diagnosis of mitochondrial neurogastrointestinal encephalomyopathy: proposal of a clinical algorithm. Dig Liver Dis 46:664–665

Zimmer V, Zimmer A, Hirano M et al (2009) Recalcitrant vomiting, disturbed eye movements, and leukoencephalopathy. Mitochondrial neurogastrointestinal encephalomyopathy. Gastroenterology 137:1581